| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 08/10/2005 | CN1652782A Nicotinamide derivatives useful as PDE4 inhibitors |
| 08/10/2005 | CN1652779A Treatment of chemokine mediated diseases |
| 08/10/2005 | CN1652777A Combination of organic compounds |
| 08/10/2005 | CN1652776A N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 08/10/2005 | CN1652772A (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1, 3-dione: methods of using and compositions thereof |
| 08/10/2005 | CN1652743A Hair growth tonic |
| 08/10/2005 | CN1652741A External preparations for skin |
| 08/10/2005 | CN1652687A Choline-silicic acid complex with osmolytes and divalent trace elements |
| 08/10/2005 | CN1651458A Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 08/10/2005 | CN1651431A Inhibitors of alpha L beta 2 mediated cell adhesion |
| 08/10/2005 | CN1651084A Injection liquid for eliminating skin umbilication defect and its preparation method |
| 08/10/2005 | CN1651069A Spot dispelling capsule and its preparation method |
| 08/10/2005 | CN1651038A Medicine for treating psoriasis |
| 08/10/2005 | CN1651016A Biological polysaccharide polymer lichen inhibiting film agent and its preparation method |
| 08/10/2005 | CN1651012A Chinese medicinal composition for treating sore and wound infection |
| 08/10/2005 | CN1651006A Chinese medicinal composition for treating youth pox colour spot |
| 08/10/2005 | CN1650995A Itching relieving medicament |
| 08/10/2005 | CN1650948A Plaster for burn pain stopping and its dispensing method |
| 08/10/2005 | CN1650933A Chinese medicinal liquid for treating alopecia and its production method |
| 08/10/2005 | CN1650925A Plaster for treating shank sore |
| 08/10/2005 | CN1650913A Anti inflammation pain stopping external use Chinese medicine for treating wound infection |
| 08/10/2005 | CN1650892A Water soluble medicament for anti inflammation, repressing bacteria, eliminating pes off smell and treating asjike, and its application |
| 08/10/2005 | CN1650867A Ketoconazole thymol solution for treating psoriasis |
| 08/10/2005 | CN1650861A Medicinal solution for treating ulceration and inflammation |
| 08/10/2005 | CN1214043C Humanized antibodies to gamma-interferon |
| 08/10/2005 | CN1214039C 3-nitrogen-6,7-dioxygen steroids and uses thereof |
| 08/10/2005 | CN1214022C Vitamin D analogues |
| 08/10/2005 | CN1214006C Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments |
| 08/10/2005 | CN1213980C Vitamin D analogues |
| 08/10/2005 | CN1213767C Topical compositions comprising ascomycins |
| 08/10/2005 | CN1213765C Liquid medicine for treating psoriasis and its prepn process |
| 08/10/2005 | CN1213748C Composition containing unionized surfactant and active component and application thereof |
| 08/10/2005 | CN1213745C Composition containing at least one compound containing phenyloxime fragment |
| 08/10/2005 | CN1213726C Resorcinol compsn. |
| 08/10/2005 | CN1213724C Local compsn. contg. tocopherol |
| 08/09/2005 | US6927317 Modulating ramp activity |
| 08/09/2005 | US6927234 possessing anti-cancer activity, anti-inflammatory activity, anti-obesity activity, and/or hair growth promotion activity |
| 08/09/2005 | US6927228 Biphenyl compounds usefuf in treatment of human and veterinary medicines such as dermatology, cardivovascular diseases, immune diseases or diseases associated with lipid metabolisms, or in cosmetic formulation |
| 08/09/2005 | US6927222 Compounds |
| 08/09/2005 | US6927219 Secondary amides such as N-Adamantan-1-methyl-2-chloro-5-(3,5-dioxo-4,5-dihydro-3H- (1,2,4)triazin-2-yl)-benzamide used as antagonists for biological receptors; antiinflammatiory, anticarcinogenic or antiischemic agents |
| 08/09/2005 | US6927218 Aryl N-cyanoguanidines and methods related thereto |
| 08/09/2005 | US6927206 treating dermatological conditions related to rosacea by topically applying a composition comprising at least one peptide copper complex to an area of affected skin |
| 08/09/2005 | US6927205 Compositions and methods for treatment of psoriasis |
| 08/09/2005 | US6927060 Generation of preferential progenitor cells; obtain cells, separate progenitor cells, progagate and recover preferential progenitor cells |
| 08/09/2005 | US6926898 Albumin fusion proteins |
| 08/09/2005 | CA2310627C Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 08/09/2005 | CA2095659C Heteroatoms-containing tricyclic compounds |
| 08/06/2005 | CA2470403A1 Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders |
| 08/06/2005 | CA2457214A1 Photodynamic therapy for the treatment of acne |
| 08/04/2005 | WO2005070443A1 Timber bark extract |
| 08/04/2005 | WO2004007457A3 Substituted benzylamine derivatives and methods of use |
| 08/04/2005 | US20050171354 Heterocyclic amines such as (2S,3S)-3-((1R)-6-methoxy-1-methyl -1-trifluoromethylisochroman-7-yl)methylamino-2-phenyl piperidine, used as analgesics, antiinflammatory agents, or for prophylaxis of cardiovascular disorders |
| 08/04/2005 | US20050171350 Benzhydryl derivatives |
| 08/04/2005 | US20050171347 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 08/04/2005 | US20050171345 Pteridine compounds for the treatment of psoriasis |
| 08/04/2005 | US20050171338 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 08/04/2005 | US20050171211 vanillylalkyl-(methyl)oxyalkyl-carbonyl derivatives; tyrosinase inhibitor; antioxidant; foods, drugs, cosmetics; reduce lipid peroxide via oxidation; prevent speckles and spots; less toxicity |
| 08/04/2005 | US20050171183 Indole-type inhibitors of p38 kinase |
| 08/04/2005 | US20050171178 Exo-1-methyl-1H-imidazole-4-sulfonic acid {3-[6-ethyl-3-(2-hydroxy-indan-2-ylmethyl)-3-aza-bicyclo[3.1.0]hex-6-yl]-phenyl}-amide; opioid receptors (mu, kappa and delta) antagonists; not substrate of the variable enzyme CYP2D6; addiction to an opiates, alcohol; obesity |
| 08/04/2005 | US20050171174 Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
| 08/04/2005 | US20050171153 Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases |
| 08/04/2005 | US20050171149 antioxidant properties and peroxisome proliferator activated receptors (PPAR) alpha and PPAR gamma activator properties; cardiovascular diseases, syndrome X, restenosis, diabetes, obesity, hypertension, inflammatory diseases, cancers or neoplasms, neurodegenerative, and skin disorders |
| 08/04/2005 | US20050171134 such as 4-[4-(1-Amino-1-methylethyl)phenyl]-5-chloro-N-[4-(2-hydroxyethyl)phenyl]pyrimidine-2-amine used as tyrosine kinase inhibitors, for prophylaxis disease states associated with angiogenesis |
| 08/04/2005 | US20050171128 Pyrrolo[2,3-d]pyrimidine compounds |
| 08/04/2005 | US20050171125 Novel alkoxypyridine-derivatives |
| 08/04/2005 | US20050171123 Quinazoline derivatives as medicaments |
| 08/04/2005 | US20050171122 Mitotic kinesin inhibitors |
| 08/04/2005 | US20050171117 Preparation of pharmaceutical salts |
| 08/04/2005 | US20050171111 E.g., 4-[[5-[[4-(3-chlorophenyl)-1,2-dihydro-2-oxo-6-quinolinyl]hydroxymethyl]-1H-imidazol-1-yl]methyl]-benzonitrile; prevents the membrane attachment of p21ras and blocks the aberrant growth of ras-transformed tumors |
| 08/04/2005 | US20050171104 Novel thyroid receptor ligands |
| 08/04/2005 | US20050171101 Neurodegenerative diseases; diseases ascribed by NMDA- and NO-induced neurotoxicity ; ischemia; antiinflammatory; anticancer; antidiabetic; 2-{3-[4-Phenyl-3,6-dihydro-1(2H)-pyridyl]propyl}-6(5H)-phenanthridinone |
| 08/04/2005 | US20050171096 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
| 08/04/2005 | US20050171094 Pyrrolopyrimidine derivatives |
| 08/04/2005 | US20050171092 Chemical compounds |
| 08/04/2005 | US20050171091 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
| 08/04/2005 | US20050171084 Methods of treatment with lxr modulators |
| 08/04/2005 | US20050171078 Cholinergic ligands at the nicotinic acetylcholine receptors; diseases related to the cholinergic system; neurodegenerative disorders; pain; antiinflammatory; diagnostic or monitoring tools using labelled forms; 3-Phenyletynyl-quinuclidin-2-ene |
| 08/04/2005 | US20050171075 Substitued 19-nor-cholestenes; antineoplastic agents, wound healing agents, antiinflammatory agents; autoimmune diseases, transplant rejection inhibition, hyperplasia, graft versus host disease; increased cell growth modulation and differentiation, low calcemic activity |
| 08/04/2005 | US20050171068 Novel 4-dedimethylaminotetracycline derivatives |
| 08/04/2005 | US20050171047 Immunostimulatory nucleic acid molecules |
| 08/04/2005 | US20050171019 Administering an exendin modified with a polymer such as polyethylene glycol, gelatin and/or albumin to increase its biological half-life; treating hyperglucagonemia and diabetes, especially type II diabetes |
| 08/04/2005 | US20050170327 Isolating thrombocytes from whole blood via agglutinating and sedimenting erthrocytes; regenerative medicine; tisssue engineering |
| 08/04/2005 | US20050170007 Ude of a mare's milk concentrate dried on a highly-dispersed, biologically inert matrix |
| 08/04/2005 | US20050169967 Surgical material comprising water glass fibres |
| 08/04/2005 | US20050169918 selectively targeting; screening an effect of a Chemokine receptor (CCR4) modulating agent; adjusting the adhesion of T cells to endothelial cells; treating inflammatory skin disease; side effect reduction without affecting on other cells |
| 08/04/2005 | CA2554234A1 Use of low-dose erythropoietin for stimulating endothelial precursor cells, regenerating organs, and slowing down progression of end organ damages |
| 08/04/2005 | CA2495839A1 Anti-photoaging cosmeceutical composition |
| 08/03/2005 | EP1559726A2 Growth differentiation factor-10 |
| 08/03/2005 | EP1559715A1 N-[2-chloro-4-(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-n'-(5-methyl-3-isoxazolyl)urea salt in crystalline form |
| 08/03/2005 | EP1559709A1 Heterocycle-containing carboxylic acid derivative and drug containing the same |
| 08/03/2005 | EP1559425A1 Peroral preparation for prevention of or treatment for atopic dermatitis |
| 08/03/2005 | EP1559422A1 Receptor function controlling agent |
| 08/03/2005 | EP1558589A2 Compounds, compositions, and methods |
| 08/03/2005 | EP1558228A1 Topical administration of basic antifungal compositions to treat fungal infections of the nails |
| 08/03/2005 | EP1399446B1 2,6,9-substituted purine derivatives and their use in the treatment of proliferative disorders |
| 08/03/2005 | EP1330455B1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 08/03/2005 | EP1330166B1 Food grade transglutaminase inhibitor and uses thereof |
| 08/03/2005 | EP1287017B1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity |
| 08/03/2005 | EP1283708B1 Use of biguanide derivatives for making a medicine having a wound healing effect |
| 08/03/2005 | EP1228059B1 Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof |